BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 26090888)

  • 21. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran.
    Emrahi L; Tabrizi MT; Gharehsouran J; Ardebili SM; Estiar MA
    Clin Lab; 2016; 62(5):757-64. PubMed ID: 27348999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
    Fokstuen S; Lyle R; Munoz A; Gehrig C; Lerch R; Perrot A; Osterziel KJ; Geier C; Beghetti M; Mach F; Sztajzel J; Sigwart U; Antonarakis SE; Blouin JL
    Hum Mutat; 2008 Jun; 29(6):879-85. PubMed ID: 18409188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
    Wang Y; Wang Z; Yang Q; Zou Y; Zhang H; Yan C; Feng X; Chen Y; Zhang Y; Wang J; Zhou X; Ahmad F; Hui R; Song L
    PLoS One; 2013; 8(6):e67087. PubMed ID: 23840593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
    Brion M; Allegue C; Gil R; Blanco-Verea A; Carracedo A; Pagannone E; Evangelista A; Di Castro S; Marchitti S; Stanzione R; Volpe M; Rubattu S
    Ann Clin Lab Sci; 2010; 40(3):285-9. PubMed ID: 20689143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy.
    Hirota T; Kubo T; Kitaoka H; Hamada T; Baba Y; Hayato K; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Doi YL
    J Cardiol; 2010 Jul; 56(1):59-65. PubMed ID: 20350521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy.
    Jørgenrud B; Jalanko M; Heliö T; Jääskeläinen P; Laine M; Hilvo M; Nieminen MS; Laakso M; Hyötyläinen T; Orešič M; Kuusisto J
    PLoS One; 2015; 10(8):e0134184. PubMed ID: 26267065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261 G > A mutation in cardiac myosin-binding protein C gene].
    Wang SX; Zou YB; Fu CY; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):17-20. PubMed ID: 17386157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.
    Rubattu S; Bozzao C; Pennacchini E; Pagannone E; Musumeci BM; Piane M; Germani A; Savio C; Francia P; Volpe M; Autore C; Chessa L
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.
    Cecconi M; Parodi MI; Formisano F; Spirito P; Autore C; Musumeci MB; Favale S; Forleo C; Rapezzi C; Biagini E; Davì S; Canepa E; Pennese L; Castagnetta M; Degiorgio D; Coviello DA
    Int J Mol Med; 2016 Oct; 38(4):1111-24. PubMed ID: 27600940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
    Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
    Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selected mutations in the myosin binding protein C gene in the Polish population of patients with hypertrophic cardiomyopathy.
    Rudziński T; Selmaj K; Drozdz J; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Aug; 66(8):821-5; discussion 826-7. PubMed ID: 18803133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation.
    van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M
    Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy.
    Lin J; Zheng DD; Tao Q; Yang JH; Jiang WP; Yang XJ; Song JP; Jiang TB; Li X
    Can J Cardiol; 2010 Dec; 26(10):518-22. PubMed ID: 21165360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
    Seeger T; Shrestha R; Lam CK; Chen C; McKeithan WL; Lau E; Wnorowski A; McMullen G; Greenhaw M; Lee J; Oikonomopoulos A; Lee S; Yang H; Mercola M; Wheeler M; Ashley EA; Yang F; Karakikes I; Wu JC
    Circulation; 2019 Feb; 139(6):799-811. PubMed ID: 30586709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
    Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
    Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.